-
1
-
-
0026884262
-
Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status?
-
Drummond M. Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status? Health Econ 1992;1:85-92.
-
(1992)
Health Econ
, vol.1
, pp. 85-92
-
-
Drummond, M.1
-
2
-
-
78049346289
-
Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods
-
Roberts RR, Scott RD, 2nd, Hota B et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010;48:1026-35.
-
(2010)
Med Care
, vol.48
, pp. 1026-1035
-
-
Roberts, R.R.1
Scott 2nd, R.D.2
Hota, B.3
-
3
-
-
77954102849
-
Is there a relationship between early statin compliance and a reduction in healthcare utilization?
-
Aubert RE, Yao J, Xia F et al. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care 2010;16:459-66.
-
(2010)
Am J Manag Care
, vol.16
, pp. 459-466
-
-
Aubert, R.E.1
Yao, J.2
Xia, F.3
-
4
-
-
0034939933
-
Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
-
Gabriel SE, Wagner JL, Zinsmeister AR et al. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Arthritis Rheum 2001;44:1504-14.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1504-1514
-
-
Gabriel, S.E.1
Wagner, J.L.2
Zinsmeister, A.R.3
-
5
-
-
0033203745
-
Does the severity of mood and anxiety symptoms predict health care utilization?
-
Nease DE, Jr, Volk RJ, Cass AR. Does the severity of mood and anxiety symptoms predict health care utilization? J Fam Pract 1999;48:769-77.
-
(1999)
J Fam Pract
, vol.48
, pp. 769-777
-
-
Nease Jr, D.E.1
Volk, R.J.2
Cass, A.R.3
-
6
-
-
22244435962
-
Incorporation of uncertainty in health economic modelling studies
-
O'Hagan A, McCabe C, Akehurst R et al. Incorporation of uncertainty in health economic modelling studies. Pharmacoeconomics 2005;23:529-36.
-
(2005)
Pharmacoeconomics
, vol.23
, pp. 529-536
-
-
O'Hagan, A.1
McCabe, C.2
Akehurst, R.3
-
7
-
-
0030011253
-
Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial
-
Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996;15:1447-58.
-
(1996)
Stat Med
, vol.15
, pp. 1447-1458
-
-
Chaudhary, M.A.1
Stearns, S.C.2
-
8
-
-
0024989695
-
The CE plane: a graphic representation of costeffectiveness
-
Black WC. The CE plane: a graphic representation of costeffectiveness. Med Decis Making 1990;10:212-4.
-
(1990)
Med Decis Making
, vol.10
, pp. 212-214
-
-
Black, W.C.1
-
9
-
-
0037232949
-
Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies
-
Zethraeus N, Johannesson M, Jonsson B et al. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003;21:39-48.
-
(2003)
Pharmacoeconomics
, vol.21
, pp. 39-48
-
-
Zethraeus, N.1
Johannesson, M.2
Jonsson, B.3
-
11
-
-
0030179629
-
Confidence intervals for costeffectiveness ratios: an application of Fieller's theorem
-
Willan AR, O'Brien BJ. Confidence intervals for costeffectiveness ratios: an application of Fieller's theorem. Health Econ 1996;5:297-305.
-
(1996)
Health Econ
, vol.5
, pp. 297-305
-
-
Willan, A.R.1
O'Brien, B.J.2
-
12
-
-
0035875885
-
Incremental net benefit in randomized clinical trials
-
Willan AR, Lin DY. Incremental net benefit in randomized clinical trials. Stat Med 2001;20:1563-74.
-
(2001)
Stat Med
, vol.20
, pp. 1563-1574
-
-
Willan, A.R.1
Lin, D.Y.2
-
13
-
-
0031967923
-
Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results
-
Tambour M, Zethraeus N. Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results. Health Econ 1998;7:143-7.
-
(1998)
Health Econ
, vol.7
, pp. 143-147
-
-
Tambour, M.1
Zethraeus, N.2
-
15
-
-
0030916397
-
The negative side of cost-effectiveness analysis
-
author reply 1932-3
-
Stinnett AA, Mullahy J. The negative side of cost-effectiveness analysis. J Am Med Assoc 1997;277:1931-2; author reply 1932-3.
-
(1997)
J Am Med Assoc
, vol.277
, pp. 1931-1932
-
-
Stinnett, A.A.1
Mullahy, J.2
-
16
-
-
0031900689
-
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
-
Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998;18(2 Suppl):S68-80.
-
(1998)
Med Decis Making
, vol.18
, Issue.2 SUPPL.
-
-
Stinnett, A.A.1
Mullahy, J.2
-
17
-
-
0036767312
-
Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data
-
Stevens JW, O'Hagan A. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data. Int J Technol Assess Health Care 2002;18:782-90.
-
(2002)
Int J Technol Assess Health Care
, vol.18
, pp. 782-790
-
-
Stevens, J.W.1
O'Hagan, A.2
-
18
-
-
0032879736
-
Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and bootstrap confidence intervals
-
Severens JL, De Boo TM, Konst EM. Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and bootstrap confidence intervals. Int J Technol Assess Health Care 1999;15:608-14.
-
(1999)
Int J Technol Assess Health Care
, vol.15
, pp. 608-614
-
-
Severens, J.L.1
De Boo, T.M.2
Konst, E.M.3
-
19
-
-
0030836029
-
Confidence intervals for cost-effectiveness ratios: a comparison of four methods
-
Polsky D, Glick HA, Willke R et al. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Econ 1997;6:243-52.
-
(1997)
Health Econ
, vol.6
, pp. 243-252
-
-
Polsky, D.1
Glick, H.A.2
Willke, R.3
-
20
-
-
0035869680
-
Bayesian costeffectiveness analysis from clinical trial data
-
O'Hagan A, Stevens JW, Montmartin J. Bayesian costeffectiveness analysis from clinical trial data. Stat Med 2001;20:733-53.
-
(2001)
Stat Med
, vol.20
, pp. 733-753
-
-
O'Hagan, A.1
Stevens, J.W.2
Montmartin, J.3
-
21
-
-
0034010546
-
Inference for the costeffectiveness acceptability curve and cost-effectiveness ratio
-
O'Hagan A, Stevens JW, Montmartin J. Inference for the costeffectiveness acceptability curve and cost-effectiveness ratio. Pharmacoeconomics 2000;17:339-49.
-
(2000)
Pharmacoeconomics
, vol.17
, pp. 339-349
-
-
O'Hagan, A.1
Stevens, J.W.2
Montmartin, J.3
-
22
-
-
0037207519
-
Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
-
O'Hagan A, Stevens JW. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Econ 2003;12:33-49.
-
(2003)
Health Econ
, vol.12
, pp. 33-49
-
-
O'Hagan, A.1
Stevens, J.W.2
-
24
-
-
0036946477
-
Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies
-
O'Hagan A, Stevens JW. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Stat Methods Med Res 2002;11:469-90.
-
(2002)
Stat Methods Med Res
, vol.11
, pp. 469-490
-
-
O'Hagan, A.1
Stevens, J.W.2
-
25
-
-
0034950339
-
A framework for cost-effectiveness analysis from clinical trial data
-
O'Hagan A, Stevens JW. A framework for cost-effectiveness analysis from clinical trial data. Health Econ 2001;10:303-15.
-
(2001)
Health Econ
, vol.10
, pp. 303-315
-
-
O'Hagan, A.1
Stevens, J.W.2
-
26
-
-
0036946469
-
Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods
-
O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 2002;11:455-68.
-
(2002)
Stat Methods Med Res
, vol.11
, pp. 455-468
-
-
O'Brien, B.J.1
Briggs, A.H.2
-
27
-
-
0033761319
-
Definition, interpretation and calculation of cost-effectiveness acceptability curves
-
Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ 2000;9:623-30.
-
(2000)
Health Econ
, vol.9
, pp. 623-630
-
-
Lothgren, M.1
Zethraeus, N.2
-
28
-
-
0036203753
-
Statistical determination of cost-effectiveness frontier based on net health benefits
-
Laska EM, Meisner M, Siegel C et al. Statistical determination of cost-effectiveness frontier based on net health benefits. Health Econ 2002;11:249-64.
-
(2002)
Health Econ
, vol.11
, pp. 249-264
-
-
Laska, E.M.1
Meisner, M.2
Siegel, C.3
-
29
-
-
0030666453
-
The usefulness of average cost-effective ratios
-
Laska EM, Meisner M, Siegel C. The usefulness of average cost-effective ratios. Health Econ 1997;6:497-504.
-
(1997)
Health Econ
, vol.6
, pp. 497-504
-
-
Laska, E.M.1
Meisner, M.2
Siegel, C.3
-
30
-
-
0030849288
-
Statistical inference for costeffectiveness ratios
-
Laska EM, Meisner M, Siegel C. Statistical inference for costeffectiveness ratios. Health Econ 1997;6:229-42.
-
(1997)
Health Econ
, vol.6
, pp. 229-242
-
-
Laska, E.M.1
Meisner, M.2
Siegel, C.3
-
31
-
-
0034088238
-
Fieller's method and net health benefits
-
Heitjan DF. Fieller's method and net health benefits. Health Econ 2000;9:327-35.
-
(2000)
Health Econ
, vol.9
, pp. 327-335
-
-
Heitjan, D.F.1
-
32
-
-
0032943122
-
Bayesian estimation of cost-effectiveness ratios from clinical trials
-
Heitjan DF, Moskowitz AJ, Whang W. Bayesian estimation of cost-effectiveness ratios from clinical trials. Health Econ 1999;8:191-201.
-
(1999)
Health Econ
, vol.8
, pp. 191-201
-
-
Heitjan, D.F.1
Moskowitz, A.J.2
Whang, W.3
-
33
-
-
0032894376
-
Problems with interval estimates of the incremental cost-effectiveness ratio
-
Heitjan DF, Moskowitz AJ, Whang W. Problems with interval estimates of the incremental cost-effectiveness ratio. Med Decis Making 1999;19:9-15.
-
(1999)
Med Decis Making
, vol.19
, pp. 9-15
-
-
Heitjan, D.F.1
Moskowitz, A.J.2
Whang, W.3
-
34
-
-
0035669803
-
Representing uncertainty: the role of cost-effectiveness acceptability curves
-
Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87.
-
(2001)
Health Econ
, vol.10
, pp. 779-787
-
-
Fenwick, E.1
Claxton, K.2
Sculpher, M.3
-
35
-
-
0032925086
-
A Bayesian approach to stochastic cost-effectiveness analysis
-
Briggs AH. A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ 1999;8:257-61.
-
(1999)
Health Econ
, vol.8
, pp. 257-261
-
-
Briggs, A.H.1
-
36
-
-
0034086702
-
Handling uncertainty in cost-effectiveness models
-
Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000;17:479-500.
-
(2000)
Pharmacoeconomics
, vol.17
, pp. 479-500
-
-
Briggs, A.H.1
-
37
-
-
0033573275
-
Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation
-
Briggs AH, Mooney CZ, Wonderling DE. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Stat Med 1999;18:3245-62.
-
(1999)
Stat Med
, vol.18
, pp. 3245-3262
-
-
Briggs, A.H.1
Mooney, C.Z.2
Wonderling, D.E.3
-
38
-
-
0036246479
-
Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies
-
Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 2002;23:377-401.
-
(2002)
Annu Rev Public Health
, vol.23
, pp. 377-401
-
-
Briggs, A.H.1
O'Brien, B.J.2
Blackhouse, G.3
-
39
-
-
0030853766
-
Pulling costeffectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation
-
Briggs AH, Wonderling DE, Mooney CZ. Pulling costeffectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
-
(1997)
Health Econ
, vol.6
, pp. 327-340
-
-
Briggs, A.H.1
Wonderling, D.E.2
Mooney, C.Z.3
-
40
-
-
0030666452
-
Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'
-
Briggs A, Fenn P. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'. Health Econ 1997;6:491-5.
-
(1997)
Health Econ
, vol.6
, pp. 491-495
-
-
Briggs, A.1
Fenn, P.2
-
41
-
-
0029366453
-
Confidence intervals for cost/effectiveness ratios
-
Wakker P, Klaassen MP. Confidence intervals for cost/effectiveness ratios. Health Econ 1995;4:373-81.
-
(1995)
Health Econ
, vol.4
, pp. 373-381
-
-
Wakker, P.1
Klaassen, M.P.2
-
42
-
-
0031989253
-
Some reflections on costeffectiveness analysis
-
Johannesson M, Meltzer D. Some reflections on costeffectiveness analysis. Health Econ 1998;7:1-7.
-
(1998)
Health Econ
, vol.7
, pp. 1-7
-
-
Johannesson, M.1
Meltzer, D.2
-
43
-
-
0032408402
-
Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane
-
Briggs A, Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998;7:723-40.
-
(1998)
Health Econ
, vol.7
, pp. 723-740
-
-
Briggs, A.1
Fenn, P.2
-
44
-
-
33745248689
-
Nonparametric statistical methods for costeffectiveness analyses
-
Dinh P, Zhou XH. Nonparametric statistical methods for costeffectiveness analyses. Biometrics 2006;62:576-88.
-
(2006)
Biometrics
, vol.62
, pp. 576-588
-
-
Dinh, P.1
Zhou, X.H.2
-
45
-
-
17844409064
-
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus
-
Reed SD, Anstrom KJ, Bakhai A et al. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J 2005;149:434-43.
-
(2005)
Am Heart J
, vol.149
, pp. 434-443
-
-
Reed, S.D.1
Anstrom, K.J.2
Bakhai, A.3
-
46
-
-
27744468588
-
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report
-
Ramsey S, Willke R, Briggs A et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8:521-33.
-
(2005)
Value Health
, vol.8
, pp. 521-533
-
-
Ramsey, S.1
Willke, R.2
Briggs, A.3
-
47
-
-
58349110979
-
Assessing the impact of drug use on hospital costs
-
Stuart BC, Doshi JA, Terza JV. Assessing the impact of drug use on hospital costs. Health Serv Res 2009;44:128-44.
-
(2009)
Health Serv Res
, vol.44
, pp. 128-144
-
-
Stuart, B.C.1
Doshi, J.A.2
Terza, J.V.3
-
48
-
-
60349109642
-
Extreme regression models for characterizing high-cost patients
-
Gregori D, Petrinco M, Barbati G et al. Extreme regression models for characterizing high-cost patients. J Eval Clin Pract 2009;15:164-71.
-
(2009)
J Eval Clin Pract
, vol.15
, pp. 164-171
-
-
Gregori, D.1
Petrinco, M.2
Barbati, G.3
-
49
-
-
41149096954
-
Regression tree boosting to adjust health care cost predictions for diagnostic mix
-
Robinson JW. Regression tree boosting to adjust health care cost predictions for diagnostic mix. Health Serv Res 2008;43:755-72.
-
(2008)
Health Serv Res
, vol.43
, pp. 755-772
-
-
Robinson, J.W.1
-
50
-
-
58849165404
-
Hospital costs estimation and prediction as a function of patient and admission characteristics
-
Ramiarina R, Almeida RM, Pereira WC. Hospital costs estimation and prediction as a function of patient and admission characteristics. Int J Health Plann Manage 2008;23:345-55.
-
(2008)
Int J Health Plann Manage
, vol.23
, pp. 345-355
-
-
Ramiarina, R.1
Almeida, R.M.2
Pereira, W.C.3
-
51
-
-
9644302446
-
Patients with type 2 diabetes had higher rates of hospitalization than the general population
-
Bo S, Ciccone G, Grassi G et al. Patients with type 2 diabetes had higher rates of hospitalization than the general population. J Clin Epidemiol 2004;57:1196-201.
-
(2004)
J Clin Epidemiol
, vol.57
, pp. 1196-1201
-
-
Bo, S.1
Ciccone, G.2
Grassi, G.3
-
52
-
-
56449122776
-
Factors affecting hospitalization costs in Type 2 diabetic patients
-
Pagano E, Bo S, Petrinco M et al. Factors affecting hospitalization costs in Type 2 diabetic patients. J Diabetes Complications 2009;23:1-6.
-
(2009)
J Diabetes Complications
, vol.23
, pp. 1-6
-
-
Pagano, E.1
Bo, S.2
Petrinco, M.3
-
53
-
-
0141510068
-
Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction
-
Desideri A, Fioretti PM, Cortigiani L et al. Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction. Eur Heart J 2003;24:1630-9.
-
(2003)
Eur Heart J
, vol.24
, pp. 1630-1639
-
-
Desideri, A.1
Fioretti, P.M.2
Cortigiani, L.3
-
54
-
-
19944433181
-
Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial
-
Desideri A, Fioretti PM, Cortigiani L et al. Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial. Heart 2005;91:146-51.
-
(2005)
Heart
, vol.91
, pp. 146-151
-
-
Desideri, A.1
Fioretti, P.M.2
Cortigiani, L.3
-
55
-
-
0027461730
-
Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery
-
Dudley RA, Harrell FE, Jr., Smith LR et al. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. J Clin Epidemiol 1993;46:261-71.
-
(1993)
J Clin Epidemiol
, vol.46
, pp. 261-271
-
-
Dudley, R.A.1
Harrell Jr., F.E.2
Smith, L.R.3
-
56
-
-
0033050856
-
On the use of survival analysis techniques to estimate medical care costs
-
Etzioni RD, Feuer EJ, Sullivan SD et al. On the use of survival analysis techniques to estimate medical care costs. J Health Econ 1999;18:365-80.
-
(1999)
J Health Econ
, vol.18
, pp. 365-380
-
-
Etzioni, R.D.1
Feuer, E.J.2
Sullivan, S.D.3
-
57
-
-
0031897990
-
Predicting the cost of illness: a comparison of alternative models applied to stroke
-
Lipscomb J, Ancukiewicz M, Parmigiani G et al. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making 1998;18(2 Suppl):S39-56.
-
(1998)
Med Decis Making
, vol.18
, Issue.2 SUPPL.
-
-
Lipscomb, J.1
Ancukiewicz, M.2
Parmigiani, G.3
-
58
-
-
0034993174
-
Estimating log models: to transform or not to transform?
-
Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461-94.
-
(2001)
J Health Econ
, vol.20
, pp. 461-494
-
-
Manning, W.G.1
Mullahy, J.2
-
59
-
-
0028510646
-
Statistical analysis of cost outcomes in a randomized controlled clinical trial
-
Rutten-van Molken MP, van Doorslaer EK, van Vliet RC. Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Econ 1994;3:333-45.
-
(1994)
Health Econ
, vol.3
, pp. 333-345
-
-
Rutten-van Molken, M.P.1
van Doorslaer, E.K.2
van Vliet, R.C.3
-
60
-
-
26044462174
-
Assessing household health expenditure with Box-Cox censoring models
-
Chaze JP. Assessing household health expenditure with Box-Cox censoring models. Health Econ 2005;14:893-907.
-
(2005)
Health Econ
, vol.14
, pp. 893-907
-
-
Chaze, J.P.1
-
61
-
-
4344617705
-
Comparing alternative models: log vs Cox proportional hazard?
-
Basu A, Manning WG, Mullahy J. Comparing alternative models: log vs Cox proportional hazard? Health Econ 2004;13:749-65.
-
(2004)
Health Econ
, vol.13
, pp. 749-765
-
-
Basu, A.1
Manning, W.G.2
Mullahy, J.3
-
62
-
-
7044221846
-
Multiple regression of cost data: use of generalised linear models
-
Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004;9:197-204.
-
(2004)
J Health Serv Res Policy
, vol.9
, pp. 197-204
-
-
Barber, J.1
Thompson, S.2
-
63
-
-
16244380534
-
Generalized modeling approaches to risk adjustment of skewed outcomes data
-
Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24:465-88.
-
(2005)
J Health Econ
, vol.24
, pp. 465-488
-
-
Manning, W.G.1
Basu, A.2
Mullahy, J.3
-
64
-
-
0036523763
-
A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment
-
Kilian R, Matschinger H, Loeffler W et al. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. J Ment Health Policy Econ 2002;5:21-31.
-
(2002)
J Ment Health Policy Econ
, vol.5
, pp. 21-31
-
-
Kilian, R.1
Matschinger, H.2
Loeffler, W.3
-
65
-
-
68349116023
-
Some notes on parametric link functions in clinical research
-
Baldi I, Maule M, Bigi R et al. Some notes on parametric link functions in clinical research. Stat Methods Med Res 2009;18:131-44.
-
(2009)
Stat Methods Med Res
, vol.18
, pp. 131-144
-
-
Baldi, I.1
Maule, M.2
Bigi, R.3
-
66
-
-
51949111620
-
Smearing estimate: a non parametric retransformation method
-
Duan N. Smearing estimate: a non parametric retransformation method. J Am Stat Assoc 1983;78:605-10.
-
(1983)
J Am Stat Assoc
, vol.78
, pp. 605-610
-
-
Duan, N.1
-
67
-
-
3142702323
-
Tobit models: a survey
-
Amemiya T. Tobit models: a survey. J Econ 1981;24:3-61.
-
(1981)
J Econ
, vol.24
, pp. 3-61
-
-
Amemiya, T.1
-
68
-
-
0001565817
-
On the asymptotic bias of the ordinary least squares estimator of the Tobit model
-
Greene WH. On the asymptotic bias of the ordinary least squares estimator of the Tobit model. Econometrica 1981;49:505-13.
-
(1981)
Econometrica
, vol.49
, pp. 505-513
-
-
Greene, W.H.1
-
69
-
-
34548741391
-
A two-part model for censored medical cost data
-
Tian L, Huang J. A two-part model for censored medical cost data. Stat Med 2007;26:4273-92.
-
(2007)
Stat Med
, vol.26
, pp. 4273-4292
-
-
Tian, L.1
Huang, J.2
-
70
-
-
42249092645
-
A computer program for estimating the re-transformed mean in heteroscedastic two-part models
-
Zhou XH, Cheng H. A computer program for estimating the re-transformed mean in heteroscedastic two-part models. Comput Methods Programs Biomed 2008;90:210-6.
-
(2008)
Comput Methods Programs Biomed
, vol.90
, pp. 210-216
-
-
Zhou, X.H.1
Cheng, H.2
-
71
-
-
56449122776
-
Factors affecting hospitalization costs in Type 2 diabetic patients
-
Pagano E, Bo S, Petrinco M et al. Factors affecting hospitalization costs in Type 2 diabetic patients. J Diabetes Complications 2009;23:1-6.
-
(2009)
J Diabetes Complications
, vol.23
, pp. 1-6
-
-
Pagano, E.1
Bo, S.2
Petrinco, M.3
-
72
-
-
84947396376
-
A generalization of sampling without replacement from a finite universe
-
Horvitz DG, Thompson DJ. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc 1952;47:663-85.
-
(1952)
J Am Stat Assoc
, vol.47
, pp. 663-685
-
-
Horvitz, D.G.1
Thompson, D.J.2
-
73
-
-
0001149964
-
Estimating medical cost with censored data
-
Bang H, Tsiatis A. Estimating medical cost with censored data. Biometirka 2000;87:329-43.
-
(2000)
Biometirka
, vol.87
, pp. 329-343
-
-
Bang, H.1
Tsiatis, A.2
-
74
-
-
0030910046
-
Estimating medical costs from incomplete follow-up data
-
Lin DY, Feuer EJ, Etzioni R et al. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53: 419-34.
-
(1997)
Biometrics
, vol.53
, pp. 419-434
-
-
Lin, D.Y.1
Feuer, E.J.2
Etzioni, R.3
-
75
-
-
35148881504
-
On the equivalence of some medical cost estimators with censored data
-
Zhao H, Bang H, Wang H et al. On the equivalence of some medical cost estimators with censored data. Stat Med 2007;26:4520-30.
-
(2007)
Stat Med
, vol.26
, pp. 4520-4530
-
-
Zhao, H.1
Bang, H.2
Wang, H.3
-
76
-
-
2342567056
-
On estimators of medical costs with censored data
-
O'Hagan A, Stevens JW. On estimators of medical costs with censored data. J Health Econ 2004;23:615-25.
-
(2004)
J Health Econ
, vol.23
, pp. 615-625
-
-
O'Hagan, A.1
Stevens, J.W.2
-
77
-
-
7744238303
-
Bootstrap confidence intervals for medical costs with censored observations
-
Jiang H, Zhou XH. Bootstrap confidence intervals for medical costs with censored observations. Stat Med 2004;23:3365-76.
-
(2004)
Stat Med
, vol.23
, pp. 3365-3376
-
-
Jiang, H.1
Zhou, X.H.2
-
78
-
-
0024401372
-
A linear regression model for the analysis of life times
-
Aalen OO. A linear regression model for the analysis of life times. Stat Med 1989;8:907-25.
-
(1989)
Stat Med
, vol.8
, pp. 907-925
-
-
Aalen, O.O.1
-
79
-
-
0027185065
-
Further results on the non-parametric linear regression model in survival analysis
-
Aalen OO. Further results on the non-parametric linear regression model in survival analysis. Stat Med 1993;12: 1569-88.
-
(1993)
Stat Med
, vol.12
, pp. 1569-1588
-
-
Aalen, O.O.1
-
80
-
-
48249139863
-
Survival models for cost data: the forgotten additive approach
-
Pagano E, Petrinco M, Desideri A et al. Survival models for cost data: the forgotten additive approach. Stat Med 2008;27:3585-97.
-
(2008)
Stat Med
, vol.27
, pp. 3585-3597
-
-
Pagano, E.1
Petrinco, M.2
Desideri, A.3
-
81
-
-
49349099514
-
Proper modeling strategies selection for the assessment of post-infarction costs
-
Gregori D, Desideri A, Bigi R et al. Proper modeling strategies selection for the assessment of post-infarction costs. Int J Cardiol 2008;129:53-8.
-
(2008)
Int J Cardiol
, vol.129
, pp. 53-58
-
-
Gregori, D.1
Desideri, A.2
Bigi, R.3
-
82
-
-
0036561353
-
The medical expenditure panel survey: an overview
-
Cohen SB. The medical expenditure panel survey: an overview. Eff Clin Pract 2002;5(3 Suppl):E1.
-
(2002)
Eff Clin Pract
, vol.5
, Issue.3 SUPPL.
-
-
Cohen, S.B.1
-
83
-
-
0041305855
-
Regression-based sampling for persons with high health expenditures: evaluating accuracy and yield with the 1997 MEPS
-
Moeller JF, Cohen SB, Mathiowetz NA et al. Regression-based sampling for persons with high health expenditures: evaluating accuracy and yield with the 1997 MEPS. Med Care 2003; 41(7 Suppl):III44-52.
-
(2003)
Med Care
, vol.41
, Issue.7 SUPPL.
-
-
Moeller, J.F.1
Cohen, S.B.2
Mathiowetz, N.A.3
-
84
-
-
33750532528
-
Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter?
-
Gregori D, Pagano E, Rosato R et al. Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter? Curr Med Res Opin 2006;22:1965-71.
-
(2006)
Curr Med Res Opin
, vol.22
, pp. 1965-1971
-
-
Gregori, D.1
Pagano, E.2
Rosato, R.3
-
85
-
-
67651155895
-
Issues for the next generation of health care cost analyses
-
Basu A, Manning WG. Issues for the next generation of health care cost analyses. Med Care 2009;47(7 Suppl 1): S109-14.
-
(2009)
Med Care
, vol.47
, Issue.7 SUPPL. 1
-
-
Basu, A.1
Manning, W.G.2
-
86
-
-
0030910046
-
Estimating medical costs from incomplete follow up data
-
Lin D, Feuer E, Etzioni R et al. Estimating medical costs from incomplete follow up data. Biometrics 1997;53:419-34.
-
(1997)
Biometrics
, vol.53
, pp. 419-434
-
-
Lin, D.1
Feuer, E.2
Etzioni, R.3
|